Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Debt Ratio (2021 - 2025)

Historic Debt Ratio for Ascendis Pharma A (ASND) over the last 5 years, with Q4 2025 value amounting to 0.63.

  • Ascendis Pharma A's Debt Ratio fell 1039.91% to 0.63 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.63, marking a year-over-year decrease of 1039.91%. This contributed to the annual value of 0.63 for FY2025, which is 1039.91% down from last year.
  • Latest data reveals that Ascendis Pharma A reported Debt Ratio of 0.63 as of Q4 2025, which was down 1039.91% from 0.57 recorded in Q3 2025.
  • In the past 5 years, Ascendis Pharma A's Debt Ratio registered a high of 0.78 during Q2 2024, and its lowest value of 0.05 during Q4 2021.
  • For the 5-year period, Ascendis Pharma A's Debt Ratio averaged around 0.58, with its median value being 0.59 (2025).
  • Its Debt Ratio has fluctuated over the past 5 years, first surged by 85293.49% in 2022, then crashed by 2871.71% in 2025.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Debt Ratio stood at 0.05 in 2021, then soared by 852.93% to 0.5 in 2022, then skyrocketed by 33.18% to 0.67 in 2023, then grew by 4.7% to 0.7 in 2024, then dropped by 10.4% to 0.63 in 2025.
  • Its Debt Ratio stands at 0.63 for Q4 2025, versus 0.57 for Q3 2025 and 0.56 for Q2 2025.